2016 tables: Institutions - corporate

The 2016 tables are based on Nature Index data from 1 January 2015 to 31 December 2015.

Table criteria

# Institution Share 2015 Count 2015
1 IBM Corporation, United States of America (USA) 62.14 134
2 Merck & Co., Inc., United States of America (USA) 26.32 56
3 Pfizer Inc., United States of America (USA) 20.58 58
4 Amgen Inc., United States of America (USA) 17.02 48
5 Bristol-Myers Squibb (BMS), United States of America (USA) 14.05 31
6 Eli Lilly and Company, United States of America (USA) 10.98 32
7 Dow Inc., United States of America (USA) 8.52 35
8 Bruker Corporation, United States of America (USA) 7.32 50
9 Johnson & Johnson, United States of America (USA) 7.12 28
10 Leidos Holdings, Inc., United States of America (USA) 7.01 72
11 Thermo Fisher Scientific Inc., United States of America (USA) 6.64 36
12 Aerodyne Research, Inc. (ARI), United States of America (USA) 5.80 28
13 Science Systems and Applications, Inc. (SSAI), United States of America (USA) 5.70 28
14 Microsoft Corporation, United States of America (USA) 5.66 27
15 General Electric Company (GE), United States of America (USA) 5.66 13
16 New England Biolabs, Inc. (NEB), United States of America (USA) 5.63 12
17 Xerox Corporation, United States of America (USA) 5.39 17
18 Ionis Pharmaceuticals, Inc., United States of America (USA) 4.92 20
19 Atmospheric and Environmental Research, Inc. (AER), United States of America (USA) 4.80 14
20 HRL Laboratories LLC, United States of America (USA) 4.49 7
21 Waters Corporation, United States of America (USA) 4.44 12
22 Regeneron Pharmaceuticals, Inc., United States of America (USA) 4.43 11
23 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 4.27 28
24 Lockheed Martin Corporation, United States of America (USA) 4.26 20
25 E. I. du Pont de Nemours and Company (DuPont), United States of America (USA) 3.89 18
26 Danaher Corporation, United States of America (USA) 3.88 14
27 Illumina, Inc., United States of America (USA) 3.87 24
28 NorthWest Research Associates, Inc. (NWRA), United States of America (USA) 3.77 19
29 Agilent Technologies, Inc., United States of America (USA) 3.76 18
30 General Atomics, United States of America (USA) 3.20 21
31 Alexion Pharmaceuticals, Inc., United States of America (USA) 3.14 4
32 Gilead Sciences, Inc., United States of America (USA) 3.13 7
33 Alphabet Inc., United States of America (USA) 3.00 16
34 AbbVie Inc., United States of America (USA) 2.89 6
35 GATS Inc., United States of America (USA) 2.87 10
36 Chevron Corporation, United States of America (USA) 2.85 19
37 Promega Corporation, United States of America (USA) 2.82 8
38 Intel Corporation, United States of America (USA) 2.71 20
39 D. E. Shaw Research, United States of America (USA) 2.70 6
40 Sangamo Therapeutics Inc., United States of America (USA) 2.59 4
41 Dow AgroSciences, United States of America (USA) 2.33 3
42 Vertex Pharmaceuticals Incorporated, United States of America (USA) 2.33 6
43 OEwaves, Inc., United States of America (USA) 2.22 3
44 Western Digital Corporation, United States of America (USA) 2.08 8
45 Seattle Genetics, Inc., United States of America (USA) 2.00 2
46 Cell Signaling Technology, Inc., United States of America (USA) 1.84 13
47 General Motors (GM), United States of America (USA) 1.81 7
48 23andMe, Inc., United States of America (USA) 1.78 10
49 Raytheon Company, United States of America (USA) 1.62 12
50 Schlumberger Limited, United States of America (USA) 1.54 5
51 Alnylam Pharmaceuticals, Inc., United States of America (USA) 1.51 6
52 Schrödinger, LLC, United States of America (USA) 1.46 6
53 Pacific Biosciences of California, Inc., United States of America (USA) 1.44 6
54 Metabolon Inc., United States of America (USA) 1.43 6
55 Natera, Inc., United States of America (USA) 1.42 2
56 Procter & Gamble (P&G), United States of America (USA) 1.39 4
57 Biogen Inc., United States of America (USA) 1.36 14
58 NUSOD Institute LLC, United States of America (USA) 1.33 2
59 Adaptive Biotechnologies LLC, United States of America (USA) 1.29 5
60 Remote Sensing Systems (RSS), United States of America (USA) 1.26 3
61 MacroGenics, Inc., United States of America (USA) 1.24 2
62 Frank Orth & Associates (FOA), United States of America (USA) 1.24 2
63 Principia Biopharma, Inc., United States of America (USA) 1.24 2
64 Ford Motor Company, United States of America (USA) 1.22 4
65 Corning Incorporated, United States of America (USA) 1.21 6
66 Pharmaceutical Product Development, LLC (PPD), United States of America (USA) 1.17 2
66 Ramboll Environ, Inc., United States of America (USA) 1.17 2
67 Polyera Corporation, United States of America (USA) 1.16 9
68 Booz Allen Hamilton Inc., United States of America (USA) 1.15 2
69 Cummins Emission Solutions, United States of America (USA) 1.14 2
70 Arcadis US, Inc., United States of America (USA) 1.13 4
71 GlobalFoundries Inc., United States of America (USA) 1.13 6
72 Picarro Inc., United States of America (USA) 1.11 3
73 ConocoPhillips Company, United States of America (USA) 1.11 5
74 Personal Genome Diagnostics, Inc. (PGDx), United States of America (USA) 1.10 5
75 Momenta Pharmaceuticals, Inc., United States of America (USA) 1.09 2
76 Qualcomm Incorporated, United States of America (USA) 1.06 6
77 Calpine Corporation, United States of America (USA) 1.02 3
78 Gene By Gene, Ltd., United States of America (USA) 1.02 3
79 Verastem, Inc., United States of America (USA) 1.01 2
80 Miami Valley Biotech, United States of America (USA) 1.00 1
80 Mersana Therapeutics, Inc., United States of America (USA) 1.00 1
80 Dynamic Connections, United States of America (USA) 1.00 1
80 Catalent Pharma Solutions, United States of America (USA) 1.00 1
80 Electronic BioSciences (EBS), United States of America (USA) 1.00 1
80 ICF International, Inc., United States of America (USA) 1.00 1
80 Newomics, Inc., United States of America (USA) 1.00 1
80 Genesis Biotechnology Group, United States of America (USA) 1.00 1
80 NanoSonic, Inc., United States of America (USA) 1.00 1
80 Research Planning, Inc., United States of America (USA) 1.00 1
80 Pranalytica, Inc., United States of America (USA) 1.00 1
80 Boston Biomedical, Inc., United States of America (USA) 1.00 1
80 Cellular Research, Inc., United States of America (USA) 1.00 1
80 Soraa Inc., United States of America (USA) 1.00 1
81 FMA Research, Inc., United States of America (USA) 0.98 3
82 Tri Alpha Energy, Inc., United States of America (USA) 0.96 1
83 Profectus Biosciences, Inc., United States of America (USA) 0.95 6
84 Lycera Corp, United States of America (USA) 0.95 2
85 Facebook, Inc., United States of America (USA) 0.94 2
86 Applied Materials, Inc., United States of America (USA) 0.93 20
87 Agios Pharmaceuticals, Inc., United States of America (USA) 0.91 3
88 Lam Research Corporation, United States of America (USA) 0.91 3
89 Johnson Controls, Inc., United States of America (USA) 0.91 14
90 NuMat Technologies, United States of America (USA) 0.90 1
91 PerkinElmer, Inc., United States of America (USA) 0.90 7
92 Hysitron, Inc., United States of America (USA) 0.88 5
93 Charles River Laboratories, Inc., United States of America (USA) 0.86 1
94 Visterra, Inc., United States of America (USA) 0.85 2
95 Revalesio Corporation, United States of America (USA) 0.85 3
96 Omega Optics, Inc., United States of America (USA) 0.83 3
96 Reprogenetics, United States of America (USA) 0.83 3
97 Cleave Biosciences, United States of America (USA) 0.83 1
98 Wyle Corporate, United States of America (USA) 0.80 5
98 Human Longevity, Inc., United States of America (USA) 0.80 2
99 DeuteRx, LLC, United States of America (USA) 0.80 1
99 Matrivax R&D Corporation, United States of America (USA) 0.80 1
100 Weinberg Medical Physics, LLC, United States of America (USA) 0.78 1
100 Energy Matter Conversion Corporation (EMC2), United States of America (USA) 0.78 1

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.